If you cannot figure out if a supplement has been third-party tested, this is a major red flag
The FDA continues to explain GLP-1 drugs should not be used in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Today, experts agree that there is no real risk of thyroid cancer associated with GLP-1 drugs
Retinopathy, Macular Degeneration, and NAION GLP-1 medications may be linked to certain eye complications, mainly in people with diabetes who already have eye disease and experience rapid improvements in blood sugar
In some cases, it can get worse if blood sugar improves too quickly
Semaglutide has been marketed for over a decade in diabetes care, and SELECT outcomes data extends beyond five years
Fortunately, this is manageable